Banque Cantonale Vaudoise’s CureVac CVAC Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,000	Closed	-$17K	–	805
2024 Q2	$17K	Buy	5,000 +4,000	+400%	+$13.1K	﹤0.01%	905
2024 Q1	$3K	Hold	1,000	–	–	﹤0.01%	961
2023 Q4	$4K	Hold	1,000	–	–	﹤0.01%	983
2023 Q3	$7K	Hold	1,000	–	–	﹤0.01%	1131
2023 Q2	$10K	Hold	1,000	–	–	﹤0.01%	1115
2023 Q1	$7K	Hold	1,000	–	–	﹤0.01%	1126
2022 Q4	$6K	Hold	1,000	–	–	﹤0.01%	1131
2022 Q3	$8K	Hold	1,000	–	–	﹤0.01%	1160
2022 Q2	$14K	Hold	1,000	–	–	﹤0.01%	1156
2022 Q1	$20K	Buy	1,000 +500	+100%	+$9.98K	﹤0.01%	1150
2021 Q4	$17K	Hold	500	–	–	﹤0.01%	1199
2021 Q3	$27K	Hold	500	–	–	﹤0.01%	1130
2021 Q2	$37K	Buy	+500	New	+$50K	﹤0.01%	1082

Other funds holding CVAC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banque Cantonale Vaudoise's CVAC Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of CureVac (CVAC) in Q3 2024, closing a stake of 5,000 shares — an estimated $17K sold.

Banque Cantonale Vaudoise first reported a position in CVAC in Q2 2021 and held it in 13 quarters. The position peaked at $37K in Q2 2021. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

Banque Cantonale Vaudoise reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 5,000 CureVac shares in Q3 2024, an estimated $17K.
Banque Cantonale Vaudoise first reported a position in CureVac in Q2 2021 and held it in 13 quarters.
Banque Cantonale Vaudoise's CureVac position peaked at $37K in Q2 2021.
81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.